Venezuela Sterile Device Declaration: Sterilization Method and Validation Certificate

1. Key takeaways

A sterile device filed in Venezuela must include a declaration of sterility (Declaración de Esterilidad), and that declaration must state two things at once: the sterilization method and the validation certificate. Missing either one constitutes an incomplete item, and it is a frequent cause of rejection at both the acceptance and the review stage.

The conclusion is that the declaration looks like a single page of simple paperwork but is in fact a condensed proof of the entire sterilization validation system. Supplying only a conclusive statement that the product is sterilized by ethylene oxide, without attaching the validation certificate, does not satisfy the requirement. The document is not a summary of an outcome; it is a pointer to evidence that must be available in full.

Because the item appears trivial, it is often assigned late and to whoever happens to be assembling the administrative section. That sequencing is the reason it fails. The validation certificate normally comes from a party outside the manufacturer’s quality department, and lead times for obtaining it are set by that party, not by the project plan.

2. Legal basis

Basis of the figures: the requirement that the declaration of sterility include both the method and the validation certificate derives from descriptions of Venezuela in industry comparison material on Latin American medical device registration requirements and is labeled practical estimate. This verification did not locate a Venezuelan official instrument that could be cited directly in support of it.

3. Expert insights

Insight 1: the two contents of the declaration correspond to two different kinds of evidence. The sterilization method is a technical description — ethylene oxide, irradiation, steam. The validation certificate is a proof of conformity issued either by a third party or within the quality system. The first can be drafted by the manufacturer. The second usually has to come from the sterilization service provider or from an accredited laboratory. As a result, the lead time for this item is not under the manufacturer’s sole control, and it has to be requested from the sterilization provider well in advance rather than assembled at the end.

Insight 2: the declaration is linked to shelf life and packaging integrity. The performance of the sterile barrier system supports the shelf life claim, and the shelf life in turn supports the transport and storage conditions. Data that contradict each other across these three areas — for example, sterilization validation supporting a 3 year shelf life while the label states 5 years — constitute a substantive defect rather than a clerical one, and the correction usually requires new testing rather than a new document.

Insight 3: the sterilization requirement for reusable devices differs from that for single-use sterile devices. A reusable device requires reprocessing validation — cleaning, disinfection and validation of the number of sterilization cycles the device can withstand — not terminal product sterilization validation. Submitting the wrong type of validation results in the documentation being judged irrelevant, which is worse than an omission because it consumes review time without advancing the file.

A fourth point concerns outsourced sterilization. Where a contract sterilizer performs the process, the manufacturer’s quality system documents describe an activity it does not directly control, and reviewers are alert to that gap. The provider’s qualification status, the quality agreement between the parties and the certificate’s scope of accreditation all need to align with the product and the claimed cycle, and any inconsistency among them tends to be read as an unvalidated process rather than as a documentation error.

Finally, the declaration should be treated as a controlled document rather than a form. It states facts that are also asserted elsewhere in the file and on the product itself, and every one of those statements has to agree. Where a change of sterilizer, a change of cycle or a change of packaging material occurs after approval, the declaration is one of the documents that must be revisited, and it is frequently the one that is forgotten because it is short and appears administrative.

For devices supplied in multiple configurations, the declaration should also state clearly which configurations it covers. A family that includes both sterile and non-sterile variants is common, and a single declaration drafted for the sterile variants alone can be read as covering the whole family. The result is a mismatch between the certificate scope and the products actually distributed, which is the kind of defect that only appears during an inspection.

4. Practical recommendations

1. Request the validation certificate from the sterilization provider or the internal sterilization department at the very start of dossier compilation, and confirm that its validity period covers the expected review cycle rather than expiring mid-review.
2. Maintain a consistency check table covering four items — sterilization method, validation certificate, shelf life statement and label content — and verify each row against the others before submission.
3. For reusable devices, submit reprocessing validation with the number of tolerated cycles and the basis for that number stated explicitly, rather than a terminal sterilization validation.
4. Where sterilization is outsourced, submit the provider’s qualification evidence and the quality agreement between the parties to demonstrate that the supply chain is traceable from the device to the sterilization cycle.

5. Verification checklist

• □ The declaration of sterility states both the sterilization method and the validation certificate
• □ The validation certificate is issued by a qualified body and remains within its validity period
• □ Sterilization method, validation conclusion, shelf life statement and label content are consistent across all four items
• □ Reusable devices are supported by reprocessing validation rather than terminal product sterilization validation
• □ Where sterilization is outsourced, the provider’s qualification and the quality agreement have been submitted

Regulatory information verified as of October 29, 2026.

GRZAN provides registration support in Venezuela for manufacturers, importers and authorized representatives, including sterilization documentation review, validation certificate coordination and consistency checks across labeling and shelf life claims. For scope and document requirements, contact info@grzanglobal.com.